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 ABSTRACT 
 
Objective: The objective of this selective EBM review is to determine whether or not the use of 
fasical manipulative therapy helps to improve overall asthma quality of life by decreasing asthma 
symptoms. 
 
Study Design: Review of two randomized controlled trials (RCTs) and one case study, published 
between 2005-current, all in the English language.  
 
Data Sources: Two randomized controlled trials (RCTs) and one case study, all of which 
evaluate the effectiveness of fascial manipulative therapy as it pertains to asthma quality of life. 
All studies were found using PubMed.  
 
Outcomes Measured: The outcomes measured were an improvement of asthma quality of life 
pertaining to asthma symptoms. These improvements were based on verbal reports given by 
patients and/or guardians, asthma quality of life questionnaires, and PFTs related to morbidity 
and mortality.   
 
Results: The RCT by Mehl-Madrona et al. and the case study by Gillespie both demonstrate that 
the use of fascial manipulation therapy help to improve asthma quality of life by decreasing 
asthma symptoms. While Guiney et al. did not demonstrate a decrease in morbidity and mortality 
associated with an increase in PFTs, the study does report patients “feeling better” after receiving 
fascial manipulation therapy. 
 
Conclusions: The results of this review demonstrate that there is evidence to support that the use 
of fascial manipulation therapy can improve overall asthma quality of life by helping to decrease 
asthma symptoms. While there was no documented decrease in morbidity and mortality, all three 
studies showed that the use of fascial manipulation therapy, such as craniosacral and myofascial 
release Osteopathic Manipulative Treatment (OMT), can release myofascial tension and help 
patients to “breathe better”. 
 
Key Words: Asthma, Manipulation Therapy 
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INTRODUCTION 
 Asthma is a chronic inflammatory disorder of the lungs. An asthma attack is 
characterized by inflammation leading to reversible obstruction of the airways, resulting in a 
difficulty in breathing.4 In 2011, the Center for Disease Control and Prevention reported that in 
the US alone there were approximately 18.9 million adults and 7.1 million children living with 
asthma.6 These numbers account for 8.2% of the total adult population and 9.5% of the total 
children population.6 In 2010 the CDC reported that 14.2 million Americans visited their primary 
care physician office with asthma as their primary diagnosis and another 1.8 million Americans 
visited the emergency department with asthma as their primary diagnosis.6 With the number of 
medical visits for asthma related complaints it is not surprising that asthma has an estimated 
annual healthcare cost of $56.0 billion.5  
The severity of asthma varies from patient to patient. Asthma can range from mild to 
severe and life threatening, leading to death if not promptly and properly dealt with. The 
strongest predisposing factor of asthma is atopy, a genetic disposition to develop an allergic 
reaction. Common allergens, prone to triggering an asthma attack, include house dust mites, 
cockroaches, animal dander, seasonal pollens, and cigarette smoke.4 An asthma attack can be 
initiated by either extrinsic, allergic, or intrinsic, non-allergic, factors. Exposure to such factors 
leads to airway inflammation by a variety of mechanisms including: cellular infiltration by 
eosinophils, neutrophils and lymphocytes; goblet cell hyperplasia leading to an increase in 
mucus production; thickening of the basement membrane due to collagen deposition; 
hypertrophy of bronchial smooth.4 All such mechanisms cause a narrowing of the airways 
leading to classic symptoms such as wheezing, dyspnea, chest tightness, coughing, and excess 
sputum production.4   
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Conventional asthma treatment is based on the severity of a patient’s asthma and involves 
the use of various types of pharmacologic agents to reduce inflammation and control asthma 
symptoms. Quick-relief medications for acute asthma exacerbations include inhaled short-acting 
beta-2-agonists and anticholinergics.4 Long-term control medications intended for better overall 
control of asthma include systemic corticosteroids, inhaled long-acting beta-2-agonists, inhaled 
long-acting anticholinergics, leukotriene modifiers, phosphodiesterase inhibitors, 
immunomodulators, and combination medications.4  
While there is currently no cure for asthma, all of the above listed medications have been 
demonstrated to help control asthma by reducing symptoms. Nevertheless, there is still a pursuit 
for an intervention that will help to further reduce asthma symptoms without the use of 
pharmacologic agents. This paper evaluates two randomized controlled trials and one case study 
in determining the efficacy of fascial manipulative therapy in improving asthma quality of life by 
decreasing asthma symptoms. The term fascial manipulative therapy encompasses osteopathic 
manipulative (OM) techniques including rib raising, muscle energy for ribs, myofascial release, 
and craniosacral therapy (CST). Andrew Taylor Still, M.D., D.O. founded osteopathic medicine 
in the 19th century on the basis that there is a myofascial system that links all parts of the body. 
Andrew Taylor Still developed techniques which involved manipulation of the myofascial 
system to “improve circulation and correct altered mechanics” of the body to treat illness and 
disease.8 Osteopathic manipulative treatment (OMT) has long been used by osteopathic doctors 
to provide relief for muscle aches and pains with the use of stretching, gentle pressure, and 
resistance.7 These techniques are now being used for trial with other health problems such as 
asthma, carpal tunnel syndrome, and migraines, among others, to complement or even replace 
pharmacological agents and surgery.7 
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OBJECTIVE 
The objective of this selective EBM review is to determine whether or not the use of 
fascial manipulative therapy helps to improve overall asthma quality of life by decreasing asthma 
symptoms. 
 
METHODS 
This review includes two randomized controlled trials (RCTs) and one case study, all of 
which evaluate the effectiveness of fascial manipulative therapy as it pertains to asthma quality 
of life. The population studied includes males and females ages 5-80 years old who have been 
previously diagnosed with asthma. The interventions used were OMT techniques that included 
craniosacral therapy and myofascial release therapy. Mehl-Madrona et al. used 12 sessions 
lasting 45 minutes each over a six week period of craniosacral therapy.3 Guiney et al. used 
Osteopathic manipulative treatment (OMT) including rib raising, muscle energy for ribs, and 
myofascial release.2 Gillespie used craniosacral fascial therapy at seven one-hour visits during 
which the diaphragm, lungs, tracheobronchial tree, throat, neck, cranium, and nasal sinuses were 
manipulated to relieve soft tissue strain and free the respiratory system.1 The comparisons 
studied included prior use of standard asthma medications such as anti-inflammatory drugs 
(corticosteroids) and bronchodilators, as well as comparison to “sham procedures” performed by 
allopathic physicians to account for a “therapeutic touch” variable. Measured outcomes 
comprised of improvement of asthma quality of life as reported by participants and also a 
possible decrease in asthma related morbidity and mortality rates as measured by increased 
pulmonary function.  
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Table 1 – demographics & Characteristics of included studies 
 
 
 
Study Type # Pts 
Age 
(yrs) 
Inclusion 
Criteria Exclusion Criteria W/D Interventions 
Gillespie, 
2008 (1) 
Case 
Study 1 
9 
y/o 
9 y/o Caucasian 
boy with a 
primary 
diagnosis of 
advanced 
asthma 
N/A 0 
Craniosacral fascial 
therapy: Seven one-
hour visits during 
which the diaphragm, 
lungs, tracheobronchial 
tree, throat, neck, 
cranium, and nasal 
sinuses were 
manipulated to relieve 
soft tissue strain and 
free the respiratory 
system. 
Guiney, 
2005 (2) RCT 140 
5-17 
y/o 
Asthmatic 
children of 
African 
American or 
Hispanic race 
between the 
ages of 5 and 17 
years old 
selected from 
the pediatric 
asthma clinic of 
Peninsula 
Hospital Center 
in Far 
Rockaway, NY. 
Patients in acute 
distress; Patients 
who demonstrated 
a lack of 
cooperation with 
study protocols – 
or were otherwise 
unable to 
participate in 
measuring PEF; 
older than 18 y/o 
or younger than 4 
y/o 
 
0 
Osteopathic 
manipulative treatment 
(OMT) including rib 
raising, muscle energy 
for ribs, and 
myofascial release VS. 
“Sham procedure” 
performed by an 
allopathic physician 
simulating OMT in 
order to control for a 
“therapeutic touch” 
variable. 
Mehl-
Madrona, 
2007 (3) 
RCT 89 
20-
80 
y/o 
Meet the criteria 
for diagnosis of 
asthma as 
defined by the 
National Heart, 
Lung, and Blood 
Institute 
National Asthma 
Education and 
Prevention 
Program; Class 
II through IV 
asthma sufferers 
were included 
Under 18 y/o; 
acupuncture or 
craniosacral 
therapy in past 6 
months; pregnant; 
on steroids 
unrelated to 
asthma; diagnosis 
of only mild 
intermittent 
asthma; life-
threatening 
conditions 
 
21 
12 sessions lasting 45 
minutes each over a six 
week period of 
craniosacral therapy 
vs. attention control or 
standard of care 
control. 
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 Keywords used in the searches were “asthma” and “manipulation therapy”. All articles 
were published in peer-reviewed journals and in the English language. The articles were 
researched via PubMed and selected based on their relevance to my clinical question and if they 
included patient oriented outcomes.  
Inclusion criteria included: studies were randomized controlled trials or case studies 
published between 2005-current, patients between the ages of 5-80 years old with a previous 
diagnosis of asthma as defined by the National Heart, Lung, and Blood Institute National Asthma 
Education and Prevention Program. Exclusion criteria included: patients ages <5 years old or 
>80 years old, patients in acute distress, patients involved in other research studies, who were 
pregnant, taking steroids unrelated to asthma, or subjects with life-threatening conditions or 
serious psychiatric conditions that would interfere with their ability to participate in the study 
and follow-up period. Summary statistics were reported using p-value and t-test.  
OUTCOMES MEASURED 
 The outcomes measured an improvement of asthma quality of life pertaining to asthma 
symptoms. Gillespie measured an improvement of asthma quality of life based on reports by the 
patient and patient’s mother relating to an improvement in symptoms and a decrease in 
frequency of asthma attacks. Mehl-Madrona et al. measured outcomes using an asthma quality of 
life questionnaire and a medication form which the patient reported the name, dose, and 
frequency of medication use. The asthma quality of life questionnaires were analyzed using 
independent samples t tests, difference scores comparing pretreatment baseline, posttreatment, 3-
month follow-up, and 6-month follow-up. One-way analysis of variance was then performed 
with post hoc tests with P values adjusted by Schade correction for multiple comparisons. 
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Guiney et al. used patient’s symptoms in correlation with PEFs to estimate pulmonary function 
as a predictor of asthma related morbidity and mortality.  
RESULTS 
 Results from two randomized controlled trials and one case study are evaluated in this 
review. The demographics and characteristics of the three studies reviewed are displayed in 
Table 1. All three studies contained continuous data that could not be converted to dichotomous 
format. Test statistics reported by the authors include p-values, mean changes from baseline, 
difference scores, independent t-tests, and one-way analysis of variance with post hoc tests with 
P values adjusted by the Schade correction for multiple comparisons.  
 In the case study by Gillespie1, a nine-year-old Caucasian boy presented with a known 
diagnosis of asthma. Since the age of two months old the participant had been on various 
regiments for asthma treatment including albuterol, levalbuterol hydrochloride, cromolyn, 
fluticasone propionate and salmeterol, montelukast, and prednisone.1 The intervention in this 
case study was seven one-hour visits consisting of craniosacral fascial therapy to release 
craniosacral and fascial strains to improve asthma symptoms over a 30 day period.1 In this study 
the patient was compliant with the treatment schedule outlined and developed no adverse effects 
from treatment. Both the patient and the patient’s mother reported improvement of asthma 
symptoms verbally. After only one treatment session the patient reported being able to “breathe 
more freely” and the patient’s mother stated that the boy was more verbally active the day after 
treatment.1 At the third visit the patient’s mother stated that she had stopped the all asthma 
medication after the first visit and that the child had not needed to take any of his prescribed 
medication due to asthma symptoms in the past two weeks.1 After the fourth visit the mother 
reports that the cough the child normally develops in the middle of winter was gone despite the 
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fact the child remained off of his asthma medications.1 By the end of the 30 day treatment period 
the patient’s mother reported that the child was still off of his medications, was cough free, and 
was able to play football outside on one of the coldest days of winter without developing asthma 
symptoms.1  
 The RCT by Mehl-Madrona et al.3 assessed the effects of craniosacral therapy on asthma 
quality of life. The intervention involved 12 standard craniosacral therapy treatments, each 
treatment lasted approximately 45 minutes, over a six week period.3 There were a total of 89 
participants in the study. The number of participants at the end of the study was 68, accounting 
for a 24% loss.3 No participant dropped out of the study due to adverse effects from the 
treatment. No adverse effects were reported by any participant in the entire study.3 A modified 
intention to treat analysis was used. If a participant completed one treatment and then withdrew 
from the study they were invited back to have a posttreatment analysis, otherwise they were not 
included in the final results analysis.3 The craniosacral therapy treatment group was compared to 
two control groups: a standard of care control group in which participants were instructed to 
maintain their normal asthma care regimens and an attention control group in which participants 
received six sessions of sham craniosacral therapy and six one-on-one educational classes. Due 
to the small group sizes at the end of the study the groups were collapsed into “treatment” and 
“control” groups for analysis purposes.3 Asthma quality of life questionnaires were completed by 
each participant on four occasions: pretreatment, post-treatment, a three-month follow-up, and a 
six-month follow-up. Asthma quality of life questionnaire mean scores for the treatment and 
control groups are displayed in Table 2. Difference scores were calculated to reduce within-
subjects variance. There are statistically significant differences between the control and treatment 
groups when comparing asthma quality of life pretreatment and posttreatment scores (Table 2). 
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With the confidence interval set at 95% the greatest variance was noted between the difference 
score pretreatment and post-treatment with a mean difference of 3.61 and a P value of 0.004 
(Table 2).3 Although not as ample as the immediate post-treatment score, the three month follow-
up still displays a statistically significant difference.3  
 
Table 2: Mehl-Madrona et al3: Comparisons of Means Between Asthma Quality of Life 
(part 1) Scores and Difference Scores From Baseline Across Assessment Periods 
 
 The RCT by Guiney et al.2 evaluated the effects of osteopathic manipulative treatment 
(OMT) on pediatric patients with asthma. This study contained 140 participants, all of which 
remained in the study until its conclusion. The participants were divided into two groups: 90 
were placed in the OMT group and 50 were placed in the control group.2 Guiney et al. postulated 
that OMT may be a treatment method to help decrease asthma related morbidity and mortality in 
pediatric patients.2 Guiney et al. measured PEFs to estimate pulmonary function as an indirect 
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measure of morbidity and mortality. The treatment group received OMT, which included rib 
raisings; muscle energy for ribs, and myofascial release while the control group received a sham 
procedure performed by an allopathic physician. PEFs were measured before and after the OMT 
or sham procedure. Results were then analyzed using t tests (Table 3).2 Based on osteopathic 
principles, the use of OMT can be used to maximize the motion of the musculoskeletal system 
which improves the overall function of the respiratory system and allows the patient to breathe 
better.2 The use of OMT was able to increase pulmonary function with a mean of 13 L per 
minute and percent difference of 4.8% in PEFs compared to the control group which had a mean 
increase of 0.3 L per minute in pulmonary function and a percent difference of 1.4% in PEFs 
(Table 3).2 There was a positive correlation noted between the increase in pulmonary function 
and the patients “feeling better.”2 However, there was no demonstration of a significant decrease 
in morbidity and mortality.2 The authors suggest that further testing with a larger sample size and 
long-term follow up is needed.2 
 
Table 3: Guiney et al.2: Peak Expiratory Flow Rates for Pediatric Patients with Asthma 
Summary of t Test Analysis (Liters Per Minute) 
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DISCUSSION 
 This systemic review investigated the effectiveness of fascial manipulation therapy, such 
as OMT, on asthma quality of life as demonstrated in two RCTs and one case study. The case 
study by Gillespie and the RCT by Guiney et al evaluated pediatric patients with asthma over the 
age of 5 years old. The remaining RCT by Mehl-Madrona et al evaluated adult patients with 
asthma between the ages of 20 and 80 years old. Each of the three studies described a positive 
correlation between fascial manipulation therapy and improvement of asthma quality of life.  
 A limitation of this literature review is that it involved search parameters that only 
included publications from 2005 to January 2013, which excluded any prior publications. Each 
of the included studies had their own limitations. The case study by Gillespie, while it 
demonstrated a profound relationship between the use of craniosacral therapy as an effective 
approach to improving asthma symptoms, only contained a sample size of one. Further research 
is needed in order to determine a more definitive relationship.  
 Guiney et al. contained participants that were selected from the pediatric asthma clinic of 
Peninsula Hospital Center in Far Rockaway, NY. A sample size containing a wider population 
distribution may help to strengthen the validity of the results. Another limitation in the RCT by 
Guiney et al. is that the study only included one session of either OMT or the sham procedure. 
Therefore, the study was unable to assess long-term treatment effects.  
 Mehl-Madrona et al. contained a moderately high dropout rate, 24% lost, which is source 
of potential bias. Mehl-Madrona et al. also had an unforeseeable and uncontrollable situation that 
may have affected the outcomes. This situation was the fact that the 9/11 attacks occurred in the 
middle of the intervention period of the study. Because environmental factors can play a 
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significant role in asthma symptoms, the increased levels of smoke and dust from the 9/11 
attacks may have altered the results.  
 Osteopathic manipulation treatment (OMT), which includes techniques such as 
craniosacral therapy and myofascial release, has been in use since the 19th century. While OMT 
is classically known for its treatment of low back pain and musculoskeletal abnormalities, 
according to the American Osteopathic Association, OMT can also be used in the treatment of 
asthma, carpal tunnel syndrome, menstrual pain, sinus disorders, and migraines.7 The American 
Osteopathic Association also reports that OMT is covered by most insurance plans.7 
 
CONCLUSIONS 
 Asthma is a chronic condition that may range from only mild symptoms to deadly 
attacks. With 16 million Americans visiting either their primary care physician or an emergency 
department in 2010 due to a chief complaint of asthma related symptoms and an estimated 
annual healthcare cost of $56.0 billion, it is clear that further intervention is required in order to 
help improve their asthma quality of life.5,6 The results of this review demonstrate that there is 
evidence to support that the use of fascial manipulation therapy can improve overall asthma 
quality of life by helping to decrease asthma symptoms. While there was no documented 
decrease in morbidity and mortality, all three studies showed that the use of fascial manipulation 
therapy, such as craniosacral and myofascial release OMT, can release myofascial tension and 
help patients to “breathe better”. As mentioned in Guiney et al. future studies may benefit from 
the use of a single osteopathic physician performing OMT in order to eliminate potential 
differences in OMT skill levels and techniques.2 
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